Timing of infliximab and adalimumab initiation despite methotrexate in children with chronic non-infectious anterior uveitis

MLA

McCracken, Courtney, et al. “Timing of Infliximab and Adalimumab Initiation despite Methotrexate in Children with Chronic Non-Infectious Anterior Uveitis.” Eye, vol. 33, no. 4, Apr. 2019, pp. 629–39. EBSCOhost, https://doi.org/10.1038/s41433-018-0283-0.

APA

McCracken, C., Yeh, S., Jenkins, K., Travers, C., Stryker, D., Tommasello, S., Rouster-Stevens, K. A., Lambert, S. R., Prahalad, S., Drews-Botsch, C., & Angeles-Han, S. T. (2019). Timing of infliximab and adalimumab initiation despite methotrexate in children with chronic non-infectious anterior uveitis. Eye, 33(4), 629–639. https://doi.org/10.1038/s41433-018-0283-0

Chicago

McCracken, Courtney, Steven Yeh, Kirsten Jenkins, Curtis Travers, Daneka Stryker, Steven Tommasello, Kelly A. Rouster-Stevens, et al. 2019. “Timing of Infliximab and Adalimumab Initiation despite Methotrexate in Children with Chronic Non-Infectious Anterior Uveitis.” Eye 33 (4): 629–39. doi:10.1038/s41433-018-0283-0.